ATRA vs VFC · rev $128.9M vs P/E 26, rev $9.50B
Atara Biotherapeutics Inc (ATRA) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
ATRA currently screens at market cap $87.1M. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the ATRA and VFC stock pages for the full models.
Not investment advice.